Primary information |
---|
ID | antitb_1258, |
Name | 23716047 |
N-Terminal modification | RNase 7 |
C-Terminal Modification | KPKGMTSSQWFKIQHMOPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKN |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | Disulphide linkage |
Chirality | Cyclic |
Nature | 68 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Secreted by innate cells during host defense |
Inhibition Concentration | Mycobacterium vaccae |
In Vitro/ In vivo | Mycobacterium vaccae strain (ATCC 15483) |
Cell Line | MIC = 20.0 ± 0.5 μM |
Inhibition Concentration | In vitro |
Sequence | 2013 |
Cytotoxicity | None |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane depolarization and permeabilization |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial and Antiparasitic |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1259, |
Name | 23716047 |
N-Terminal modification | RNase 7 |
C-Terminal Modification | KPKGMTSSQWFKIQHMOPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKN |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | Disulphide linkage |
Chirality | Cyclic |
Nature | 68 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Secreted by innate cells during host defense |
Inhibition Concentration | Mycobacterium vaccae |
In Vitro/ In vivo | Mycobacterium vaccae strain (ATCC 15483) |
Cell Line | IC50 = 9.3 ± 1.2 μM |
Inhibition Concentration | In vitro |
Sequence | 2013 |
Cytotoxicity | None |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane depolarization and permeabilization |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial and Antiparasitic |
Tertiary Structure (Technique) | Not Predicted), |